REMIBRUTINIB

1354 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking REMIBRUTINIB:

# Side effect Count
0 URTICARIA 186
1 PETECHIAE 185
2 DRUG INEFFECTIVE 148
3 CONTUSION 130
4 PRURITUS 105
5 HEADACHE 77
6 HEAVY MENSTRUAL BLEEDING 59
7 NAUSEA 58
8 OFF LABEL USE 57
9 CONDITION AGGRAVATED 53
See all common reactions for REMIBRUTINIB

REMIBRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLEEDING RISK ASSESSMENT 1 1.0000
1 PLATELET DISTRIBUTION WIDTH DECREASED 3 0.0638
2 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 15 0.0479
3 CHRONIC SPONTANEOUS URTICARIA 44 0.0379
4 PHAGOCYTOSIS 1 0.0312
5 ANTI-THYROID ANTIBODY INCREASED 3 0.0238
6 PETECHIAE 185 0.0177
7 NASAL MUCOSAL EROSION 1 0.0175
8 HYPOAESTHESIA TEETH 2 0.0156
9 EOSINOPHIL PERCENTAGE DECREASED 3 0.0151
See all enriched reactions for REMIBRUTINIB